| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/29/2010 | US20100105767 Compounds, compositions and methods |
| 04/29/2010 | US20100105737 PYRIDINE DERIVATIVES SUBSTITUTED WITH HETEROCYCLIC RING AND gamma-GLUTAMYLAMINO GROUP, AND ANTIFUNGAL AGENTS CONTAINING SAME |
| 04/29/2010 | US20100105703 Synthetic Mimetics Of Host Defense And Uses Thereof |
| 04/29/2010 | US20100105701 Gyrase inhibitors and uses thereof |
| 04/29/2010 | US20100105698 Therapeutic Methods and Compounds |
| 04/29/2010 | US20100105696 IMIDAZOQUINOLINES AS DUAL LIPID KINASE AND mTOR INHIBITORS |
| 04/29/2010 | US20100105692 Dipterinyl Calcium Pentahydrate (DCP) and Therapeutic Methods Based Thereon |
| 04/29/2010 | US20100105673 Substituted aminofuranones and their use |
| 04/29/2010 | US20100105671 C7-fluoro substituted tetracycline compounds |
| 04/29/2010 | US20100105649 Veterinary compositions for treating mastitis |
| 04/29/2010 | US20100105626 Novel Analogues of Antimicrobial and Anticancer Peptide Synthesized and Produced from Gaegurin 5 |
| 04/29/2010 | US20100105607 Novel semi-synthetic glycopeptides as antibacterial agents |
| 04/29/2010 | US20100105603 Methods and Preparations For Curing Clinically Ill Patients |
| 04/29/2010 | US20100105602 Treatment of intracellular bacterial infections |
| 04/29/2010 | US20100104668 Nutritional supplement for honeybees |
| 04/29/2010 | US20100104648 Treatment of inflammatory and/or bacterial conditions with particles of microstructure |
| 04/29/2010 | US20100104642 Hydrophilic foam and pharmaceutical dosage form employing the same |
| 04/29/2010 | US20100104633 antifungal formulations comprising terbinafine or a pharmaceutically acceptable salt thereof, a lipid, and a surfactant; uses thereof for the treatment of skin and nail fungal infections |
| 04/29/2010 | US20100104615 Absorbent article comprising lactic acid producing bacteria |
| 04/29/2010 | US20100104607 Anti-bacterial peptides and methods of treating diseases using same |
| 04/29/2010 | US20100104600 Methods and Compositions for Increasing Tissue Tropism of Recombinant Adenoviral Vectors |
| 04/29/2010 | US20100104599 Compositions and Methods For Enhancing Immune System of Felines |
| 04/29/2010 | US20100104598 Development of dengue virus vaccine components |
| 04/29/2010 | US20100104595 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
| 04/29/2010 | US20100104594 Pathogen for bacterial poultry disease |
| 04/29/2010 | US20100104591 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 04/29/2010 | US20100104589 Immunoconjugates with an Intracellularly-Cleavable Linkage |
| 04/29/2010 | US20100104580 Altered Immunogenic Landscape in HIV-1 Envelope Proteins |
| 04/29/2010 | US20100104564 Altered Antibody Fc Regions and Uses Thereof |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104555 HCV neutralizing epitopes |
| 04/29/2010 | US20100104553 Antibodies and methods for making and using them |
| 04/29/2010 | US20100104552 Antibiotic synergism |
| 04/29/2010 | US20100104538 Beneficial effects of bacteriophage treatments |
| 04/29/2010 | US20100104533 Early intervention of viral infection with immune activators |
| 04/29/2010 | US20100104532 Nucleoside analogs for antiviral treatment |
| 04/29/2010 | US20100104507 Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo |
| 04/29/2010 | US20100104503 Modular nanoparticles for adaptable vaccines |
| 04/29/2010 | CA2741419A1 Anti-fmd vaccine composition and preparation and use thereof |
| 04/29/2010 | CA2741413A1 Novel uses |
| 04/29/2010 | CA2741368A1 Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio) acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| 04/29/2010 | CA2741333A1 Vaccine against african horse sickness virus |
| 04/29/2010 | CA2741306A1 Fosfomycin/tobramycin combinations for the treatment and prevention of ophthalmic, otological and dermatological infections |
| 04/29/2010 | CA2740982A1 Pyridine derivatives substituted with heterocyclic ring and y-glutamylamino group, and antifungal agents containing same |
| 04/29/2010 | CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2740807A1 Phenanthroindolizidine derivative and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2735956A1 Phosphodiestarase inhibitors |
| 04/29/2010 | CA2728949A1 Thiophene containing analogues of fluconazole as antifungal agents and process thereof |
| 04/29/2010 | CA2674454A1 Improved hcv vaccines and methods for using the same |
| 04/28/2010 | EP2180041A2 New lines of human hepatomas, methods for obtaining same and applications thereof |
| 04/28/2010 | EP2178886A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections |
| 04/28/2010 | EP2178885A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections |
| 04/28/2010 | EP2178878A1 Tetracyclic compounds for the treatment of hepatitis c |
| 04/28/2010 | EP2178877A1 Anti-viral compounds, compositions, and methods of use |
| 04/28/2010 | EP2178876A1 Spiro condensed barbituric acid derivatives for use as antibacterial |
| 04/28/2010 | EP2178852A1 Alkylsulfonyl-substituted thiazolide compounds |
| 04/28/2010 | EP2178840A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 04/28/2010 | EP2178827A1 Crystalline solid forms |
| 04/28/2010 | EP2178602A2 Asymmetric liposomes and uses in medical field thereof |
| 04/28/2010 | EP2178552A1 The use of type-b lantibiotic-based compounds having antimicrobial activity |
| 04/28/2010 | EP2178549A1 Antimicrobial peptide, compositions , and methods of use |
| 04/28/2010 | EP2178540A1 Pharmaceutical composition suitable for adsorption to the cell surface of pathogenic microbes |
| 04/28/2010 | EP2178533A1 Antiviral composition comprising a sulfated polysaccharide |
| 04/28/2010 | EP2178525A1 Resveratrol complex and process for the preperation |
| 04/28/2010 | EP1844776B1 Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus |
| 04/28/2010 | EP1667694B1 Tlr7 ligands for the treatment of hepatitis c |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | EP1246647B1 Non-immunosuppressant hiv tat |
| 04/28/2010 | CN1961888B Lyophilized powder injection of baikal skullcap root extract and preparation method thereof |
| 04/28/2010 | CN1956732B Antimycobacterial pharmaceutical composition comprising an antitubercular drug |
| 04/28/2010 | CN1954818B Application of phillyrin in preparation for treating endotoxemia |
| 04/28/2010 | CN1943580B New use of fumigacin type steroids in producing medicine for anti-drug fast bacteria |
| 04/28/2010 | CN1901924B Method for inhibiting bacterial colonisation |
| 04/28/2010 | CN1822843B Process for preparing an antiviral particles |
| 04/28/2010 | CN1820020B SARS-coronavirus virus-like particles and methods of use |
| 04/28/2010 | CN1798762B Tuberculosis vaccine with improved efficacy |
| 04/28/2010 | CN1796403B Polypeptide and bacterin for preventing and curing infection of polytype human being papilomavirus |
| 04/28/2010 | CN1690066B Antiviral agent cidofovir derivatives |
| 04/28/2010 | CN1688600B Template-fixed peptidomimetics with antibacterial activity |
| 04/28/2010 | CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/28/2010 | CN1641034B Method for preparing tetanus toxin recombinant antigen and its use |
| 04/28/2010 | CN1525852B Granules and granules coated with a masked taste |
| 04/28/2010 | CN1468307B Anti-dual integrin antibodies, compositions, methods and uses |
| 04/28/2010 | CN101698678A Silkworm antibacterial peptide, cDNA sequence thereof and application thereof |
| 04/28/2010 | CN101698673A Prawn white spot syndrome virus VP37p polypeptide fragment and application thereof |
| 04/28/2010 | CN101698100A Listeriosis vaccine and preparation method |
| 04/28/2010 | CN101698098A Preparation method of sustained release preparation of phytohemagglutinin |
| 04/28/2010 | CN101698089A Traditional Chinese medicine volatile oil clathrate compound and preparation method thereof |
| 04/28/2010 | CN101698080A Purple-flower holly leaf erysipelas lotion and equipment method thereof |
| 04/28/2010 | CN101698078A Traditional Chinese medicine for treating septicemia |
| 04/28/2010 | CN101698075A External scald head liniment |
| 04/28/2010 | CN101698073A Medicine for treating hepatitis B and preparation method thereof |
| 04/28/2010 | CN101698068A Medicine for treating high-pathogenicity porcine reproductive and respiratory syndrome |
| 04/28/2010 | CN101698047A Traditional Chinese medicine for treating swine erysipelas |
| 04/28/2010 | CN101698027A Traditional Chinese medicine composite for treating infectious bursal disease and preparation method thereof |
| 04/28/2010 | CN101698011A Medicine for treating epidemic diarrhea of livestock and poultry |
| 04/28/2010 | CN101698008A Antiviral capsules |
| 04/28/2010 | CN101698005A Gold granules used for treating cold and influenza and preparation method thereof |
| 04/28/2010 | CN101697973A Cefathiamidine preparation for injection and preparation method thereof |
| 04/28/2010 | CN101697969A Ornidazole medicinal composition and preparation method thereof |